Role of Glutamine Metabolism in Host Defense Against Mycobacterium tuberculosis Infection.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
19 04 2019
Historique:
received: 26 06 2018
accepted: 07 12 2018
pubmed: 13 12 2018
medline: 7 1 2020
entrez: 13 12 2018
Statut: ppublish

Résumé

Rewiring cellular metabolism is important for activation of immune cells during host defense against Mycobacterium tuberculosis. Glutamine has been implicated as an immunomodulatory nutrient, but its role in the response to M. tuberculosis is unknown. We assessed expression of glutamine pathway genes in M. tuberculosis-infected macrophages and blood transcriptomic profiles of individuals with latent M. tuberculosis infection or tuberculosis. Subsequently, we studied the effect of blocking glutaminolysis on M. tuberculosis-induced cytokines. Finally, we examined whether polymorphisms in genes involved in the glutamine pathway influence M. tuberculosis-induced cytokines in a cohort of 500 individuals. Glutamine pathway genes were differentially expressed in infected macrophages and patients with tuberculosis. Human peripheral blood mononuclear cells stimulated with M. tuberculosis displayed decreased cytokine (ie, interleukin 1β, interferon γ, and interleukin 17) responses when medium was devoid of glutamine. Specific inhibitors of the glutamine pathway led to decreased cytokine responses, especially T-cell cytokines (ie, interferon γ, interleukin 17, and interleukin 22). Finally, genetic polymorphisms in glutamine metabolism genes (including GLS2, SLC1A5, and SLC7A5) influenced ex vivo cytokine responses to M. tuberculosis, especially for T-cell cytokines. Cellular glutamine metabolism is implicated in effective host responses against M. tuberculosis. Targeting immunometabolism may represent new strategies for tuberculosis prevention and/or treatment.

Sections du résumé

BACKGROUND
Rewiring cellular metabolism is important for activation of immune cells during host defense against Mycobacterium tuberculosis. Glutamine has been implicated as an immunomodulatory nutrient, but its role in the response to M. tuberculosis is unknown.
METHODS
We assessed expression of glutamine pathway genes in M. tuberculosis-infected macrophages and blood transcriptomic profiles of individuals with latent M. tuberculosis infection or tuberculosis. Subsequently, we studied the effect of blocking glutaminolysis on M. tuberculosis-induced cytokines. Finally, we examined whether polymorphisms in genes involved in the glutamine pathway influence M. tuberculosis-induced cytokines in a cohort of 500 individuals.
RESULTS
Glutamine pathway genes were differentially expressed in infected macrophages and patients with tuberculosis. Human peripheral blood mononuclear cells stimulated with M. tuberculosis displayed decreased cytokine (ie, interleukin 1β, interferon γ, and interleukin 17) responses when medium was devoid of glutamine. Specific inhibitors of the glutamine pathway led to decreased cytokine responses, especially T-cell cytokines (ie, interferon γ, interleukin 17, and interleukin 22). Finally, genetic polymorphisms in glutamine metabolism genes (including GLS2, SLC1A5, and SLC7A5) influenced ex vivo cytokine responses to M. tuberculosis, especially for T-cell cytokines.
CONCLUSIONS
Cellular glutamine metabolism is implicated in effective host responses against M. tuberculosis. Targeting immunometabolism may represent new strategies for tuberculosis prevention and/or treatment.

Identifiants

pubmed: 30541099
pii: 5239862
doi: 10.1093/infdis/jiy709
doi:

Substances chimiques

Cytokines 0
Glutamine 0RH81L854J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1662-1670

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Valerie A C M Koeken (VACM)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.

Ekta Lachmandas (E)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.

Anca Riza (A)

Human Genomics Laboratory, Craiova University of Medicine and Pharmacy, Romania.

Vasiliki Matzaraki (V)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Yang Li (Y)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Vinod Kumar (V)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Marije Oosting (M)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.

Leo A B Joosten (LAB)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.

Mihai G Netea (MG)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.
Human Genomics Laboratory, Craiova University of Medicine and Pharmacy, Romania.

Reinout van Crevel (R)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen.
Center for Infectious Diseases, Radboud University Medical Center, Nijmegen.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH